Digital Therapeutics

Selected news for the healthcare topic - Digital Therapeutics, collected since 10/2017. There are 5.6K items in the archive. This healthcare topic shares news with Digital Health, Mental Health, Pear Therapeutics, DarioHealth, Cognitive Behavioral Therapy and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/8/2022 The Year of the Medtech CEO Turnover MDDI ... authorized for marketing by the FDA. Frank’s long track record of building and financing lifescience companies will ensure that Better Therapeutics is able to capitalize on these results and bring life-changing prescription digital therapeutics to the providers and patients who need them most.”Karbe is a seasoned executive, serving most recently as president and CFO at Myovant Sciences, where he led the company's efforts to raise $2 ...
6/7/2022 Better Therapeutics Appoints Frank Karbe as Chief Executive Officer | Business Wire Business Wire SAN FRANCISCO--( BUSINESS WIRE )-- Better Therapeutics, Inc . (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced that Frank Karbe will join the company as President and Chief Executive Officer and serve as a member of the Board of Directors starting July 5 th , 2022. Current CEO and company co-founder, Kevin Appelbaum, will continue to ...
6/7/2022 Pharmaceutical Drug Development Sector Scorecard 2022: High-Value Deals Continue to Drive the Immuno-oncology and Genomics Markets But Several Companies Sell Biosimilar Portfolios - ResearchAndMarkets.com | Business Wire Business Wire ... 2022.Many companies included in the Drug Development scorecard have continued to announce partnerships in the artificial intelligence (AI) space since December 2021. Pfizer announced three partnerships in drug discovery, disease severity scoring, and digital therapeutics . Sanofi announced a huge $5.3 billion collaboration with Exscientia in drug discovery, while Thermo Fisher Scientific announced it was partnering with Medidata Acorn AI to optimize clinical trials. Charles River Laboratories and Valo Health ...
6/7/2022 Freespira Appoints Joseph Perekupka as Chief Executive Officer to Fuel Continued Growth PR Newswire New executive brings commercialization expertise to ground-breaking digital therapeutics companyKIRKLAND, Wash. , June 7, Freespira, Inc. , maker of the first FDA-cleared digital therapeutic treatment for panic attacks, panic disorder and post-traumatic stress disorder (PTSD), today announced the appointment of Joseph Perekupka as Chief Executive Officer.Joseph Perekupka is Chief Executive Officer of Freespira, Inc. With nearly 20 years of established commercial leadership, Perekupka will oversee the next ...
6/7/2022 Pharmaceutical Drug Development Sector Scorecard 2022: High-Value Deals Continue to Drive the Immuno-oncology and Genomics Markets But Several Companies Sell Biosimilar Portfolios - ResearchAndMarkets.com Business Wire ... 2022.Many companies included in the Drug Development scorecard have continued to announce partnerships in the artificial intelligence (AI) space since December 2021. Pfizer announced three partnerships in drug discovery, disease severity scoring, and digital therapeutics . Sanofi announced a huge $5.3 billion collaboration with Exscientia in drug discovery, while Thermo Fisher Scientific announced it was partnering with Medidata Acorn AI to optimize clinical trials. Charles River Laboratories and Valo Health ...
6/6/2022 Pear Therapeutics Announces New Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Using reSET® at Six Months | Business Wire Business Wire BOSTON--( BUSINESS WIRE )-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today announced a manuscript accepted for publication and available via pre-print of a real-world study demonstrating reduced resource utilization and associated costs for reSET®, the only FDA-authorized PDT for the treatment of substance use disorder (SUD), including alcohol, cannabis, cocaine, and stimulants.Results from ...
6/6/2022 ieso Announces Results Showing Novel Form of Online Cognitive Behavioral Therapy Improves Patient Outcomes in Type 2 Diabetes Business Wire CAMBRIDGE, England--(BUSINESS WIRE)--Jun 6, 2022--ieso , a data-driven AI healthcare company pioneering next-generation digital therapeutics in mental health, announced today study results showing that integrated approaches for mental healthcare in diabetes patients improved mental health outcomes, patient engagement with self-management of diabetes, diabetes distress, and quality of life.It is estimated that 25% of patients with diabetes have comorbid depression, and 40% have comorbid anxiety ...
6/3/2022 DarioHealth Presents Three New Studies Demonstrating Improved Health in Users with Multiple Conditions at the American Diabetes Association's 82nd Scientific Sessions PR Newswire ... stress and depression.The third study demonstrates that the Dario solution has similar positive impact on diabetes across ethnicities.NEW YORK , June 3, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO ), a leader in the global digital therapeutics (DTx) market, announced today three new research studies presented at the American Diabetes Association's ("ADA") 82 nd Scientific Sessions being held June 3 rd to 7 th , 2022 in New Orleans, Louisiana .Two of ...
6/3/2022 Study backs DarioHealth's digital therapeutics for managing diabetes drugdeliverybusiness.com DarioHealth (Nasdaq:DRIO) announced today that multiple research studies support its digital therapeutics for diabetes management.New York-based DarioHealth presented the data from the new studies at the American Diabetes Association’s (ADA) 82nd Scientific Sessions in New Orleans. Two of the studies add to DarioHealth’s evidence supporting an integrated approach to managing multiple chronic conditions, while the third analyzed the impact across ethnicities of users living with ...
6/2/2022 The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis heraldkeeper.com Roots Analysis has announced the addition of “ Digital Health Market : Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” report to its list of offerings.Over 85% of digital therapeutic solutions are intended to replace medication : Such solutions are currently available / being developed ...
5/31/2022 On mental fitness beliefs, lifestyles and new tools like apps, digital therapeutics, virtual reality, “brain age gaps” and more sharpbrains.com Welcome to a new edition of SharpBrains’ e‑newsletter, featuring timely brain & mental health news and a fun couple of math brain teasers. 1. Study on the “ABCs of Mental Health” finds that simply believing you can improve mental wellbeing helps actually improve itBeliefs matter. 2. “Digital therapeutics” vs. “Mental health apps”: A growing debate on standards, regulation and efficacyDefinitions matter. 3. How ’sleeping ...
5/31/2022 Challenges Faced by Digital Therapeutics Developers MedTech Intelligence The first part of this two-article series on digital therapeutics (DTx), “ The Rise of Digital Therapeutics,” provided visibility into this growing landscape or care and outlined key considerations for developer. This second installment sheds light on challenges faced by the companies in the DTx market and outlines hurdles that must be overcome to achieve success.As a new technological course of treatment, DTx face challenges on several ...
5/30/2022 The “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 heraldkeeper.com Roots Analysis has announced the addition of “ Digital Health Market : Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” report to its list of offerings.Over 85% of digital therapeutic solutions are intended to replace medication : Such solutions are currently available / being developed ...
5/28/2022 Digital therapeutics revenue from health insurers to reach $8bn globally by 2026 safinancenews.com Digital therapeutics revenue from health insurers to reach $8bn globally by 2026With Covid-19, came a flood of new telehealth (virtual consulting) healthcare solutions, exposing more patients to its benefits and features. More advertising, more awareness and more conversations have introduced telehealth to a broader public, and this can only be good for everyone. The question remains though, how do we create that trust in telehealth for a patient ...
5/26/2022 Digital Therapeutics and Wellness Market to Witness Huge Growth by 2028 : Vida Health, Digital Therapeutics, Provant Health sbwire.com New Jersey, NJ -- ( SBWIRE ) -- 05/26/2022 -- Latest published market study on Global Digital Therapeutics and Wellness Market provides an overview of the current market dynamics in the Digital Therapeutics and Wellness space, as well as what our survey respondents—all outsourcing decision-makers—predict the market will look like in 2027. The study breaks market by revenue and volume (wherever applicable) and price history to estimates size and trend analysis and ...
5/25/2022 Digital Therapeutics Market Size to Hit US$ 13.1 Billion by 2026 onfeetnation.com Welcome toOn Feet NationSign InGrowth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics . On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of ...
5/25/2022 The Rise of Digital Therapeutics MedTech Intelligence In a healthcare landscape where the continuum of care has become increasingly technology-dependent, digital therapeutics (DTx) extend patient treatment options. DTx are a subset of digital health that deliver medical interventions directly to patients using evidence-based, clinically evaluated software to treat, manage and prevent a broad spectrum of diseases and disorders (1). DTx products are held to the same standards of evidence and regulatory oversight as traditional medical ...
5/24/2022 Digital Therapeutics Global Market Report 2022 Globe Newswire New York, Reportlinker.com announces the release of the report "Digital Therapeutics Global Market Report 2022" - https://www.reportlinker.com/p06280891/?utm_source=GNWThe global digital therapeutics market is expected to grow from $4.39 billion in 2021 to $5.51 billion in 2022 at a compound annual growth rate (CAGR) of 25.6%. The market is expected to grow to $13.27 billion in 2026 at a compound annual growth rate (CAGR) of 24.6%.The ...
5/23/2022 Asia Digital Therapeutics Market Size, Share, Outlook and COVID-19 Strategies, Forecasts from 2022 to 2028 heraldkeeper.com ... reach USD 14.54 Billion by 2027 with a CAGR of 22% over the forecast period. Technological advancement in medical sector and demand in digital healthcare facilities are key driving factors for the growth of Digital Therapeutics Market.Get Sample Copy of this Premium Report: https://bit.ly/38MQihPDigital Therapeutics Market Report Key Players:- Dario Health- Pear Therapeutics- Omada Health- Click Therapeutics- Akili Interactive- Lark Health- Kaia Health- Cognoa- othersDigital ...
5/23/2022 EY Announces Mickey Shimp of Mix Talent as an Entrepreneur Of The Year® 2022 East Central Award Finalist PR Newswire ... help companies make a positive impact on the lives of patients."Mix Talent is a talent acquisition and consulting organization built to support the near-term goals and long-term success of pharma, biotech, digital therapeutics /medtech, and gene therapy organizations. Founded in 2018, Mix Talent has grown from six to 110 teammates and for the past two years has averaged more than 38% growth year over year. Their unique ...